Cel
With 14.4 million prevalent cases and 1.7 million deaths tuberculosis (TB) remains one of the most serious infectious diseases to date. An estimated 2 billion people are believed to be infected with Mycobacterium tuberculosis and at risk of developing disease. Multi- and extensively drug resistant strains are increasingly appearing in many parts of the world, including Europe. While with current control measures the Millennium Development Goals (MDGs) set for 2015 may be achieved, reaching these would still leave a million people per year dying from TB. Much more effective measures, particularly more effective vaccines will be essential to reach the target of eliminating TB in 2050. Two successive FP5 and FP6 funded projects, Tuberculosis (TB) Vaccine Cluster (2000-2003) and TBVAC (2004-2008), have in the recent decade made significant contributions to the global TB vaccine pipeline, with four vaccines (out of nine globally) being advanced to clinical stages. Both projects strongly contributed to the strengthening and integration of expertise and led to a European focus of excellence that is unique in the area of TB vaccine development. In order to sustain and accelerate the TB vaccine developments and unique integrated excellence of TBVAC, a specific legal entity was created named TuBerculosis Vaccine Initiative (TBVI). The NEWTBVAC proposal is the FP7 successor of TBVAC, and will be coordinated by TBVI. The proposal has the following objectives : 1) To sustain and innovate the current European pipeline with new vaccine discoveries and advance promising candidates to clinical stages; 2) To design new, second generation vaccines based new prime-boost strategies and/or new (combinations of) promising subunit vaccines, that will impact on reduction of disease in exposed individuals; 3) To sustain and innovate discovery, evaluation and testing of new biomarkers, that will be critically important for future monitoring of clinical trials.
Dziedzina nauki
Zaproszenie do składania wniosków
FP7-HEALTH-2009-single-stage
Zobacz inne projekty w ramach tego zaproszenia
System finansowania
CP-IP - Large-scale integrating projectKoordynator
8219 PK LELYSTAD
Niderlandy
Zobacz na mapie
Uczestnicy (34)
2300 Kobenhavn S
Zobacz na mapie
72074 Tuebingen
Zobacz na mapie
89081 Ulm
Zobacz na mapie
2333 ZA Leiden
Zobacz na mapie
1050 BRUXELLES
Zobacz na mapie
1330 Rixensart
Zobacz na mapie
75794 Paris
Zobacz na mapie
4031 Basel
Zobacz na mapie
00161 Roma
Zobacz na mapie
1211 Geneve
Zobacz na mapie
OX1 2JD Oxford
Zobacz na mapie
91054 Erlangen
Zobacz na mapie
B4 7ET Birmingham
Zobacz na mapie
59019 Lille
Zobacz na mapie
1050 Bruxelles / Brussel
Zobacz na mapie
75724 Paris
Zobacz na mapie
136 791 SEOUL
Zobacz na mapie
50009 Zaragoza
Zobacz na mapie
80539 Munchen
Zobacz na mapie
8006 Zurich
Zobacz na mapie
35122 Padova
Zobacz na mapie
Zakończenie uczestnictwa
SW1W 9SZ London
Zobacz na mapie
2288 GJ Rijswijk Zh
Zobacz na mapie
120 749 SEOUL
Zobacz na mapie
151919 Seoul
Zobacz na mapie
6708 PB Wageningen
Zobacz na mapie
08916 Badalona Barcelona
Zobacz na mapie
WC1E 7HT London
Zobacz na mapie
90133 Palermo
Zobacz na mapie
6500 Bellinzona
Zobacz na mapie
38027 GRENOBLE
Zobacz na mapie
2500 EJ Den Haag
Zobacz na mapie
30659 HANNOVER
Zobacz na mapie
LS2 7UE Leeds
Zobacz na mapie